Belldegrun Arie

CIK 000129654911 companiesLOS ANGELES, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001296549

Recent Transactions

50 trades

Conversion
LB PHARMACEUTICALS INC$LBRX
Series C Preferred Stock
2025-09-12−30,667→ 0 total
Conversion
LB PHARMACEUTICALS INC$LBRX
Common Stock
2025-09-12+1,262→ 1,262 total
Purchase
LB PHARMACEUTICALS INC$LBRX
Common Stock
2025-09-12$15.00/sh+332,566→ 880,214 total
Purchase
LB PHARMACEUTICALS INC$LBRX
Common Stock
2025-09-12$15.00/sh+767→ 2,029 total
Conversion
LB PHARMACEUTICALS INC$LBRX
Series C Preferred Stock
2025-09-12−13,302,666→ 0 total
Conversion
LB PHARMACEUTICALS INC$LBRX
Common Stock
2025-09-12+547,648→ 547,648 total
Award
UroGen Pharma Ltd.$URGN
Stock Option (right ot buy)
2025-08-26+20,000→ 20,000 total
Disposition to Issuer
Kronos Bio, Inc.
Stock Option (Right to Buy)
2025-06-20−20,600→ 0 total
Disposition from Tender
Kronos Bio, Inc.
Common Stock
2025-06-20$0.57/sh−679,575→ 0 total
Disposition from Tender
Kronos Bio, Inc.
Common Stock
2025-06-20$0.57/sh−2,765,314→ 0 total
Disposition to Issuer
Kronos Bio, Inc.
Stock Option (Right to Buy)
2025-06-20−34,000→ 0 total
Disposition to Issuer
Kronos Bio, Inc.
Stock Option (Right to Buy)
2025-06-20−34,000→ 0 total
Disposition to Issuer
Kronos Bio, Inc.
Stock Option (Right to Buy)
2025-06-20−34,000→ 0 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2025-01-24+369,957→ 2,236,816 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to buy)
2025-01-24+1,307,927→ 1,307,927 total
Award
UroGen Pharma Ltd.$URGN
Stock Option (right ot buy)
2024-08-06+10,000→ 10,000 total
Award
Kronos Bio, Inc.
Stock Option (Right to Buy)
2024-06-25+34,000→ 34,000 total
Award
Ginkgo Bioworks Holdings, Inc.$DNA
Restricted Stock Units
2024-06-13+432,900→ 432,900 total
Award
Ginkgo Bioworks Holdings, Inc.$DNA
Stock Option
2024-06-13+571,428→ 571,428 total
Exercise/Conversion
Ginkgo Bioworks Holdings, Inc.$DNA
Restricted Stock Units
2024-06-12−105,263→ 0 total
Exercise/Conversion
Ginkgo Bioworks Holdings, Inc.$DNA
Class A Common Stock
2024-06-12+105,263→ 194,925 total
Purchase
Allogene Therapeutics, Inc.$ALLO
Common Stock
2024-05-16$2.90/sh+1,724,137→ 1,724,137 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2024-05-16$2.90/sh+344,828→ 539,867 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2024-01-25+211,973→ 1,866,859 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to buy)
2024-01-25+749,398→ 749,398 total
Award
UroGen Pharma Ltd.$URGN
Stock Option (right ot buy)
2023-09-07+10,000→ 10,000 total
Award
Kronos Bio, Inc.
Stock Option (Right to Buy)
2023-06-22+34,000→ 34,000 total
Award
Ginkgo Bioworks Holdings, Inc.$DNA
Stock Option
2023-06-16+139,860→ 139,860 total
Award
Ginkgo Bioworks Holdings, Inc.$DNA
Restricted Stock Units
2023-06-16+105,263→ 105,263 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2023-03-22+994,800→ 994,800 total
Award
Allogene Therapeutics, Inc.$ALLO
Common Stock
2023-03-22+1,282,976→ 1,654,886 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Stock Option (right to buy)
2022-09-14−160,000→ 0 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2022-09-14$5.00/sh+160,000→ 408,693 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Stock Option (right to buy)
2022-08-31−3,241→ 0 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Ordinary Shares
2022-08-31$5.00/sh+3,241→ 248,693 total
Award
Kronos Bio, Inc.
Stock Option (Right to Buy)
2022-06-22+34,000→ 34,000 total
Award
Ginkgo Bioworks Holdings, Inc.$DNA
Stock Option
2022-06-10+108,516→ 108,516 total
Award
Ginkgo Bioworks Holdings, Inc.$DNA
Class A Common Stock
2022-06-10+70,921→ 89,662 total
Award
UroGen Pharma Ltd.$URGN
Stock Option (right to buy)
2022-06-08+10,000→ 10,000 total
Award
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2022-03-23+1,458,333→ 1,458,333 total
Other
Allogene Therapeutics, Inc.$ALLO
Common Stock
2022-03-14+4,710,121→ 4,710,121 total
Other
Allogene Therapeutics, Inc.$ALLO
Common Stock
2022-03-14−4,710,120→ 0 total
Other
Allogene Therapeutics, Inc.$ALLO
Common Stock
2022-03-14−4,710,121→ 0 total
Other
Allogene Therapeutics, Inc.$ALLO
Common Stock
2022-03-14+4,710,120→ 4,710,120 total
Purchase
Allogene Therapeutics, Inc.$ALLO
Common Stock
2022-01-12$12.60/sh+155,039→ 195,039 total
Award
Kronos Bio, Inc.
Stock Option (Right to Buy)
2021-06-22+20,600→ 20,600 total
Award
UroGen Pharma Ltd.$URGN
Stock Option (right to buy)
2021-06-07+10,000→ 10,000 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Stock Option (Right to Buy)
2021-05-24−379,066→ 0 total
Exercise/Conversion
Allogene Therapeutics, Inc.$ALLO
Common Stock
2021-05-24$18.22/sh+379,066→ 583,034 total
Exercise/Conversion
UroGen Pharma Ltd.$URGN
Stock Option (right to buy)
2021-03-26−3,241→ 0 total

Companies

Recent Filings

Address

UCLA SCHOOL OF MEDICINE 10833 LE CONTE 66-118 CHS BOX 951738

LOS ANGELES, CA, 90095-1738

View on SEC.gov